CHP investigates Mycobacterium abscessus infection case involving 24-year-old woman linked to GEEL MEDICAL in Mong Kok

Picture for illustration purpose only.

5th December 2023 – (Hong Kong) The Centre for Health Protection (CHP) of the Department of Health (DH) is currently conducting an investigation into a case of Mycobacterium abscessus infection. The infection is linked to a customer who received injections at a premises operating under the name “GEEL MEDICAL” and with an associated Instagram account called “geelmedical.” Individuals who have visited “GEEL MEDICAL” and received injections or suspect they may have experienced relevant symptoms are urged to seek immediate medical attention and contact the CHP.

The investigation stems from a suspected Mycobacterium abscessus infection cluster that emerged in early November. In response, the CHP has issued multiple press releases and established a hotline for public awareness and contact tracing purposes. It is due to these efforts that the case announced today came to light.

The case involves a 24-year-old female who visited “GEEL MEDICAL” on 9th October for injection services claimed to stimulate collagen production. The premises, located at 13F, Gala Place, 56 Dundas Street, Mong Kok, administered the injection under the supervision of a registered doctor. Five days after the procedure, the patient developed a rash and abscess at the injection sites. Despite subsequent follow-up visits to the premises, her condition did not improve. On 20th November, she sought the care of another private doctor who confirmed the growth of Mycobacterium abscessus in a clinical sample obtained from the patient on 4th December Currently, the patient’s condition is stable.

Upon receiving information about the case, the CHP promptly conducted on-site investigations at the premises. These investigations encompassed a review of injection procedures, infection control measures, qualifications of personnel involved in the injections, and the potential use of unregistered pharmaceutical products. The incident may involve breaches of infection control procedures, and the CHP has collected environmental specimens and relevant apparatus for testing.

The CHP urges individuals who have visited “GEEL MEDICAL” and experienced relevant symptoms after receiving injections to seek medical attention and contact the CHP immediately. An enquiry hotline (2125 2372) has been set up and operates from Monday to Friday (excluding public holidays) between 9am and 5.30pm.